Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Michael Young who wrote (4574)	8/29/2001 2:55:21 PM
From: Jibacoa	Respond to of 52153

It looks interesting from a TA standpoint and the fact that insiders who own 73% of the shares have reportedly being buying more than selling lately. Institutions hold only 5% and have been selling. For the six months ended 6/30/01, revenues increased 11% to $7.1 million, but the net loss rose 15% to $21.7 million.They have an agreement with Acqua Wellington Equities Fund Ltd. for an equity investment in BioMarin of up to $50 million for the next year or so to sell them stock at a "discounted price".They supposedly had 60M or $1.42/share at the end of June.The loss for the ttm was $1.07 with $0.30 in the last Q. Do you have any idea how large the market is for the treatment of mucopolysaccharidosis ? Their other product for local treatment of wounds and burns is not particularly appealing to me since I have been "burned" before on products for burn treatment and local treatment of "diabetic foot ulcers".<g> From a TA standpoint they are doing well today on good volume of 172,400 and it seems it will be larger than the July 10 volume of 172,500 (it is already over the July 16 volume of 164,100) and may even match the June 15 volume of 188,900 (that was on a down day <g>) There was a recent block of 25000 shares traded at 2.33PM that went unchanged at 11.95 and since then it has made an intra-day H at 12.10 at 2.49PM on just 100 shares.<g> Bernard